September 2018

Contents

Editorial

• 19 September 2018: vol 19 no 15: UK diagnoses, U=U resources, generic PrEP

• U=U resources for UK clinics: free posters, postcards and factsheets

Special reports

• HIV diagnoses in UK drop for third year: among all ages, risk groups, and ethnicities and across most UK regions

Conference reports

• 22nd International AIDS Conference (AIDS 2018) – third reports

• Dolutegravir twice daily is effective and tolerable with rifampicin: 48 week results from the INSPIRING study

• TAF exposures during pregnancy and postpartum appear adequate but more data are needed

• High rate of unintended pregnancy among HIV positive African women on ART

Antiretrovirals

• English court finds in favour of access to generic TDF/FTC

• FDA approves doravirine (Pifeltro) and new FDC with TDF/3TC (Delstrigo) in the US

• FDA update labels for dolutegravir and dolutegravir-based FDCs to reflect potential risk of neural tube defects

On the web

• Alcohol and HIV: new issue of RITA

PDFs

• 19 September 2018: vol 19 no 15